IDH.L Share News (IDH)

Immunodiagnostic Systems Affirms Outlook, Interim Profit Hit By One-Off Costs

Wednesday broker round-up UPDATE

Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation. Bellway: Numis upgrades to buy with a target price of 1690p. Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation. Britvic: UBS ups target price from 575p to 600p and keeps a neu

AIM IN BRIEF: Albemarle & Bond Sees No Signs Of Recovery

UK BROKER RATING CHANGES: Jefferies Raises Easyjet To Buy

Monday broker round-up UPDATE

African Barrick Gold: Goldman Sachs ups target price from 110p to 140p, but still recommends selling. Alternative Asset Opps: Westhouse Securities initiates with a buy recommendation. Amino Technology: Northland Capital cuts target price from 110p to 100p and downgrades from buy to hold. Asian Pl

Thursday broker round-up UPDATE

Ashmore Group: Canaccord Genuity takes target price from 380p to 400p and retains a hold recommendation. Numis shifts target price from 380p to 390p reiterating its hold recommendation. Ashtead Group: Numis upgrades to add with a target price of 670p. Berkeley Group: Panmure Gordon moves target pr

Immunodiagnostic Systems returns to growth in first half

Faster revenue growth from its automatic diagnostic testing technology helped Immunodiagnostic Systems (IDS) return to growth in the first half, with first-half declines in its older manual devices also slower than expected. IDS said total revenues for the six months to September 30th would swell

Immunodiagnostic Systems Holdings Expects Half-Year Revenues Of GBP27 Million

Ashtead execs sell off awards after share-price surge

Equipment rental business Ashtead has seen a number of board-members sell off their share awards given to them as part of their performance share plan (PSP) in June 2010. Awards given to executives under the PSP vest on the third anniversary of grant subject to continued employment and the achievem

Immunodiagnostic Systems revenues shrink

Immunodiagnostic Systems posted reduced revenues, in the wake of tough trading conditions, as it puts in place a strategy to return the group to growth. The Newcastle-upon-Tyne based group, which makes manual and automated specialist diagnostic testing kits and instrumentation for the clinical and

Monday broker round-up UPDATE

Antofagasta: UBS reduces target price from 1140p to 1050p, while upgrading from neutral to buy. ARM Holdings: Analysts at Numis have cut their view on the shares to reduce from hold. Associated British Foods: Nomura cuts target price from 1800p to 1650p downgrading to reduce. Atkins: Jefferies u

Wednesday broker round-up UPDATE

Aberdeen Asset Management: Canaccord Genuity cuts target price from 460p to 440p, while leaving its buy recommendation unchanged. ASOS: Canaccord Genuity downgrades to hold with a target price of 3400p. BT Group: Credit Suisse increases target price from 300p to 350p and maintains an outperform ra

Wednesday broker round-up UPDATE

African Barrick Gold: Westhouse Securities upgrades from sell to neutral with a target price of 195p. Deutsche Bank reduces target price from 340p to 230p keeping its hold rating. African Minerals: Deutsche Bank reduces target price from 620p to 594p and leaves its buy recommendation unaltered. An

IDS update proves resilience and cash generation

Revenues from medical diagnostics group Immunodiagnostic Systems to the end of March will be marginally reduced on the previous year but in line with expectations. In a year-end trading update, the Newcastle-upon-Tyne based company said total revenues would hit £49.8m for the year to March 31st, d

Belvoir Lettings Chairman sells shares to satisfy institutional demand

Belvoir Lettings, the UK lettings specialist which listed on the AIM market in February last year, announced on Friday that its Executive Chairman and founder had sold a quarter of a million shares in the group in order to help satisfy 'significant institutional demand'. The news comes just a week